Literature DB >> 14717048

[Misunderstood neurological side effects of amodiaquine: apropos of 35 cases in children at Central University Hospital of Yopougon at Abidjan, Côte d' Ivoire].

L Adonis-Koffy1, T Daubrey, A Kouadio, A M Timité-Konan, J Kabran.   

Abstract

The case reports about the neurological sides effects of amodiaquine are scare, and just a few of them concerned the children. But more and more, amodiaquine is prescribed because of the resistance of Plasmodium in front of chloroquine. And, in the endemic area of malaria, there are more and more neurological side effects with amodiaquine among the children. From a retrospective study, from January 1998 to June 2000, the authors described 35 case reports of children aged from 5 months to 15 years who presented neurological side effects after taking amodiaquine in endemic malarial area. The aim of this study is, first to inform the pediatricians in our area about these side effects, as they are not mentioned in therapeutic guides. Second, it shows that it is not exceptional in the endemic area of malaria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14717048

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  2 in total

1.  Artesunate- and amodiaquine-associated extrapyramidal reactions: a series of 49 cases in VigiBase™.

Authors:  John McEwen
Journal:  Drug Saf       Date:  2012-08-01       Impact factor: 5.606

2.  Unanticipated CNS Safety Signal in a Placebo-Controlled, Randomized Trial of Co-Administered Atovaquone-Proguanil and Amodiaquine.

Authors:  Stephan Chalon; M Farouk Chughlay; Nada Abla; Andre Marie Tchouatieu; Amina Haouala; Ben Hutter; Ulrike Lorch; Fiona Macintyre
Journal:  Clin Pharmacol Ther       Date:  2021-09-14       Impact factor: 6.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.